Guardado en:
| Autores principales: | Grégoire Saltiel, Emmanuel Faure, Ady Assaf, Marie‐Charlotte Chopin, Fanny Moreau, Karine Faure, Céline Goeminne, Fanny Vuotto |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.15327 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
The impact of active cytomegalovirus infection on donor‐derived cell‐free DNA testing in heart transplant recipients
por: Amit H. Alam, et al.
Publicado: (2024)
por: Amit H. Alam, et al.
Publicado: (2024)
Postoperative cognitive dysfunction in heart transplantation recipients
por: Qian Qin, et al.
Publicado: (2024)
por: Qian Qin, et al.
Publicado: (2024)
Prevalence of iron deficiency and anemia in pediatric heart transplant recipients
por: David M. Newland, et al.
Publicado: (2024)
por: David M. Newland, et al.
Publicado: (2024)
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
por: Maria Alejandra Mendoza, et al.
Publicado: (2024)
por: Maria Alejandra Mendoza, et al.
Publicado: (2024)
Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
por: Bernard S. Kadosh, et al.
Publicado: (2024)
por: Bernard S. Kadosh, et al.
Publicado: (2024)
Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams
por: Elena M. Donald, et al.
Publicado: (2024)
por: Elena M. Donald, et al.
Publicado: (2024)
Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients
por: Sydni Martinez, et al.
Publicado: (2024)
por: Sydni Martinez, et al.
Publicado: (2024)
Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post‐transplant viremia
por: Sarah Khan, et al.
Publicado: (2024)
por: Sarah Khan, et al.
Publicado: (2024)
Immune outcomes of lung transplant recipients with different cytochrome P450 3A5 phenotypes after discontinuation of voriconazole antifungal prophylaxis
por: Zoe H. Tu, et al.
Publicado: (2024)
por: Zoe H. Tu, et al.
Publicado: (2024)
Utility of a fusion protein T‐cell co‐stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center
por: Daniel Oren, et al.
Publicado: (2024)
por: Daniel Oren, et al.
Publicado: (2024)
Lung transplantation in HIV seropositive recipients: An analysis of the UNOS registry
por: Jack K. Donohue, et al.
Publicado: (2024)
por: Jack K. Donohue, et al.
Publicado: (2024)
Letermovir for cytomegalovirus prophylaxis in lung transplant recipients: A promising shift toward reduced myelotoxicity
por: Muath Alsharif, et al.
Publicado: (2024)
por: Muath Alsharif, et al.
Publicado: (2024)
Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
por: Emily Eribes, et al.
Publicado: (2024)
por: Emily Eribes, et al.
Publicado: (2024)
Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients
por: Christie Rampersad, et al.
Publicado: (2024)
por: Christie Rampersad, et al.
Publicado: (2024)
Analysis of the waitlist performance and post‐transplant outcomes of lung transplant in elderly recipients in Korea: A nationwide cohort study
por: Jin Ho Jang, et al.
Publicado: (2024)
por: Jin Ho Jang, et al.
Publicado: (2024)
Regulatory T cells in kidney transplant recipients with LIMS1 rs893403 risk genotype
por: Safak Mirioglu, et al.
Publicado: (2024)
por: Safak Mirioglu, et al.
Publicado: (2024)
Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal
por: Sarah E Bova, et al.
Publicado: (2024)
por: Sarah E Bova, et al.
Publicado: (2024)
Risk factors and outcomes of bloodstream infection from a urinary source in kidney transplant recipients
por: Emily M. Eichenberger, et al.
Publicado: (2024)
por: Emily M. Eichenberger, et al.
Publicado: (2024)
Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients
por: Kevin D. He, et al.
Publicado: (2024)
por: Kevin D. He, et al.
Publicado: (2024)
Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
por: Jessica Hedvat, et al.
Publicado: (2024)
por: Jessica Hedvat, et al.
Publicado: (2024)
Association of physical activity with fractures in kidney transplant recipients: A Korean nationwide cohort study
por: Sungmi Kim, et al.
Publicado: (2024)
por: Sungmi Kim, et al.
Publicado: (2024)
Influence of cardiac diagnosis on outcomes of pediatric heart‐lung transplantation
por: Sandeep Sainathan, et al.
Publicado: (2024)
por: Sandeep Sainathan, et al.
Publicado: (2024)
Cardiovascular outcomes in solid organ transplant recipients undergoing cardiac surgery: A matched pair analysis
por: Kitae Kim, et al.
Publicado: (2024)
por: Kitae Kim, et al.
Publicado: (2024)
Can a “broken heart” successfully be transplanted? A brief report
por: Lorenzo Giovannico, et al.
Publicado: (2024)
por: Lorenzo Giovannico, et al.
Publicado: (2024)
Does lung procurement and exposure to Perfadex impact heart transplantation outcomes
por: David Blitzer, et al.
Publicado: (2024)
por: David Blitzer, et al.
Publicado: (2024)
Low‐dose tissue plasminogen activator is safe and effective in treating major intracardiac thrombosis in liver transplant recipients
por: Christine Nguyen‐Buckley, et al.
Publicado: (2024)
por: Christine Nguyen‐Buckley, et al.
Publicado: (2024)
Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen
por: Rachel A. Rikard, et al.
Publicado: (2024)
por: Rachel A. Rikard, et al.
Publicado: (2024)
Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort
por: Manuela Almeida, et al.
Publicado: (2024)
por: Manuela Almeida, et al.
Publicado: (2024)
Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
por: Jennifer L. Alejo, et al.
Publicado: (2024)
por: Jennifer L. Alejo, et al.
Publicado: (2024)
Assessment of immunosuppression induction with basiliximab compared to antithymocyte‐globulin in adult heart transplant patients
por: Theresa E. Eberhardt, et al.
Publicado: (2024)
por: Theresa E. Eberhardt, et al.
Publicado: (2024)
COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland
por: Sarah Ulrich, et al.
Publicado: (2024)
por: Sarah Ulrich, et al.
Publicado: (2024)
Psychological assessment of patients on the heart transplant waiting list: A single center experience
por: Simona De Santis, et al.
Publicado: (2024)
por: Simona De Santis, et al.
Publicado: (2024)
Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis
por: David Moynan, et al.
Publicado: (2024)
por: David Moynan, et al.
Publicado: (2024)
Financial impact of donation after circulatory death heart transplantation: A single‐center analysis
por: Marian Urban, et al.
Publicado: (2024)
por: Marian Urban, et al.
Publicado: (2024)
Impact of age over 70 years in the new allocation system on the outcomes of heart transplantation in the US
por: Marco Gemelli, et al.
Publicado: (2024)
por: Marco Gemelli, et al.
Publicado: (2024)
A heart transplant center experience with basiliximab induction strategies: A double edged sword?
por: Luise Holzhauser, et al.
Publicado: (2024)
por: Luise Holzhauser, et al.
Publicado: (2024)
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates
por: Nadia Fida, et al.
Publicado: (2024)
por: Nadia Fida, et al.
Publicado: (2024)
Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records
por: Krista L. Lentine, et al.
Publicado: (2024)
por: Krista L. Lentine, et al.
Publicado: (2024)
Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden
por: Carl Johan Svensson, et al.
Publicado: (2024)
por: Carl Johan Svensson, et al.
Publicado: (2024)
Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study
por: Sumeet S. Vaikunth, et al.
Publicado: (2024)
por: Sumeet S. Vaikunth, et al.
Publicado: (2024)
Ejemplares similares
-
The impact of active cytomegalovirus infection on donor‐derived cell‐free DNA testing in heart transplant recipients
por: Amit H. Alam, et al.
Publicado: (2024) -
Postoperative cognitive dysfunction in heart transplantation recipients
por: Qian Qin, et al.
Publicado: (2024) -
Prevalence of iron deficiency and anemia in pediatric heart transplant recipients
por: David M. Newland, et al.
Publicado: (2024) -
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
por: Maria Alejandra Mendoza, et al.
Publicado: (2024) -
Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
por: Bernard S. Kadosh, et al.
Publicado: (2024)